CLL-1558: Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Clinical Lymphoma Myeloma and Leukemia
Conference Name
Society of Hematologic Oncology (SOHO) Annual Meeting
Conference Date
2026-09-09 - 2026-09-12
First Page
S654
Last Page
S655
DOI
10.1016/S2152-2650(26)02126-9
Volume
26
Issue
Supplement 1
Publication Date
8-1-2026
Recommended Citation
Idriss, M., Nasim, S., Junaid, M., Shaikh, M. S., Emmama, S., & Mohiuddin, O. (2026). CLL-1558: Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia, 26 (Supplement 1), S654-S655. https://doi.org/10.1016/S2152-2650(26)02126-9
COinS